Fig. 1From: The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globallyOverview LEGACy; Indicating which centers contribute to which determination and related parts of the project. ANAX: Anaxomics SL (Spain); ECPC: European Cancer Patient Coalition (Belgium); GENPAT: Genpat SL (Paraguay); IAF: Institute Alexandre Fleming (Argentine); INCAN: Caner Insitute of Mexico (Mexico); INCLIVA: Biomedical Research Center INCLIVA (Spain); PUC: Pontificia University of Chile (Chile); ULEI: University of Leipzig (Germany); VHIO: Valld’Hebrón Insitut of Oncology (Spain); VUMC: Amsterdam UMC (Netherlands). IHC: Immunohistochemistry; ISH: In situ hybridization. Map created with mapchart.net. Figure created with BioRender.comBack to article page